Literature DB >> 24984215

Stimulation of autophagic activity in human glioma cells by anti-proliferative ardipusilloside I isolated from Ardisia pusilla.

Rong Wang1, Xin Xiao2, Peng-Yuan Wang2, Lin Wang2, Qiunong Guan3, Caigan Du4, Xiao-Juan Wang5.   

Abstract

AIMS: Ardipusilloside I (ADS-I), a triterpenoid saponin isolated from Ardisia pusilla A.DC (Myrsinaceae), has been recently tested for cancer treatment including brain cancer. However, the mechanism of its action remains elusive. The present study was to investigate the role of autophagy activation in the anti-tumor activities of ADS-I in human glioma cells. MAIN
METHODS: The tetrazolium dye (MTT) colorimetric assay was used for the measurement of cell proliferation in cultured glioma cells, transmission electron microscopy (TEM) for the examination of autophagic activity, flow cytometric analysis for the determination of cell cycle and apoptotic cells, and immunocytochemistry and Western blot for protein expression of microtubule-associated protein light-chain 3 (LC3) and Beclin 1. KEY
FINDINGS: ADS-I significantly inhibited the proliferation of both U373 and T98G glioma cells in cultures in a dose-dependent manner. The cytotoxic activity of ADS-I against glioma cell growth was associated not only with the induction of cell cycle arrest at G2/M phase and cell apoptosis in flow cytometric analysis, but also with the activation of autophagy, indicated by the formation of autophagosomes and up-regulated expression of both autophagic protein Beclin 1 and LC3 in glioma cells. Additionally, the treatment with chloroquine, an autophagy inhibitor, reduced ADS-1-mediated cell death. SIGNIFICANCE: These data suggest that the anti-proliferative activity of ADS-I in human glioma cells is associated with the activation of autophagy in addition to cell cycle arrest and apoptosis, and the antagonistic effect of chloroquine suggests an important role of autophagy in ADS-I-mediated cell death against tumor growth.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Ardipusilloside I; Ardisia pusilla; Autophagy; Human glioblastoma; Natural compound; Triterpenoid saponin

Mesh:

Substances:

Year:  2014        PMID: 24984215     DOI: 10.1016/j.lfs.2014.06.016

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Efficacy of local delivery of ardipusilloside I using biodegradable implants against cerebral tumor growth.

Authors:  Huan Dang; Ji Wang; Jiang-Xue Cheng; Peng-Yuan Wang; Ying Wang; Li-Fei Cheng; Caigan Du; Xiao-Juan Wang
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

2.  Pseudolaric acid B inhibits proliferation in SW579 human thyroid squamous cell carcinoma.

Authors:  Jinghua Yu; Peiyou Ren; Ting Zhong; Yalin Wang; Minghui Yan; Bianbian Xue; Rui Li; Chunyan Dai; Chunyu Liu; Guang Chen; Xiao-Fang Yu
Journal:  Mol Med Rep       Date:  2015-10-05       Impact factor: 2.952

Review 3.  Review of Natural Product-Derived Compounds as Potent Antiglioblastoma Drugs.

Authors:  Moon Nyeo Park; Hyo Sook Song; Myungsun Kim; Min-Jung Lee; Whisung Cho; Hyun-Jin Lee; Cho-Hyun Hwang; Soojong Kim; Yechae Hwang; Beomku Kang; Bonglee Kim
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

4.  In Search of High-Yielding and Single-Compound-Yielding Plants: New Sources of Pharmaceutically Important Saponins from the Primulaceae Family.

Authors:  Maciej Włodarczyk; Paweł Pasikowski; Kinga Osiewała; Aleksandra Frankiewicz; Andrzej Dryś; Michał Gleńsk
Journal:  Biomolecules       Date:  2020-02-29

Review 5.  Natural Compounds from Herbs that can Potentially Execute as Autophagy Inducers for Cancer Therapy.

Authors:  Shian-Ren Lin; Yaw-Syan Fu; May-Jywan Tsai; Henrich Cheng; Ching-Feng Weng
Journal:  Int J Mol Sci       Date:  2017-07-01       Impact factor: 5.923

Review 6.  Natural products: a hope for glioblastoma patients.

Authors:  Raghupathy Vengoji; Muzafar A Macha; Surinder K Batra; Nicole A Shonka
Journal:  Oncotarget       Date:  2018-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.